After dropping 54 percent yesterday on cautious FDA briefing documents, MELA Sciences, Inc. (Nasdaq: MELA) is stabilizing today ahead of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE